Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ingersoll-Rand PLC (IR), E. I. du Pont de Nemours and Company (DD): Updates on Trian Partners’ Positions

Page 1 of 2

Nelson Peltz’s Trian Partners has provided updates on two of its key activist positions in recent days, officially launching their proxy fight against E. I. du Pont de Nemours and Company (NYSE: DD), as well as greatly increasing their stake in Ingersoll-Rand PLC (NYSE:IR). Trian holds 24.31 million shares in the 212-year-old DuPont, and can now boast a 15.38 million share stake in Ingersoll-Rand, an increase of 2.56 million shares from the 12.82 million they held at the end of 2014.

Trian Partners, the activist fund founded in 2005 by Peltz along with Peter May and Edward Garden, stepped up its attack on E. I. du Pont de Nemours and Company (NYSE: DD), filing a 78-page report yesterday that detailed the company’s underperformance as it officially filed a preliminary proxy statement with regulators, to have its four nominees appointed to DuPont’s board.

The new filing comes a week after E. I. du Pont de Nemours and Company (NYSE: DD) shot down all four of those proposed nominees, including Peltz, and elected two of its own choices to its board instead. Trian refused DuPont’s overtures of a lone board spot in negotiations between the two, and insisted on the appointment of all four of its nominees, which were originally nominated by Trian on January 9.

Among other things, Trian pointed out the extreme improvement in Axalta Coating Systems Ltd (NYSE:AXTA) since it broke away from E. I. du Pont de Nemours and Company (NYSE: DD), under which it was known as DuPont Performance Coatings. DuPont sold the division to The Carlyle Group LP (NASDAQ:CG) in February 2013, and its EBITDA improved by 67% almost immediately under new ownership. Axalta went public in November, 2014, and has been a hot stock ever since, up over 25% from its IPO price.

It will now be up to shareholders to decide whether or not to support Trian’s push for board seats. Shareholders of E. I. du Pont de Nemours and Company (NYSE: DD) who may be involved in deciding the direction of the company are John A. Levin’s Levin Capital Strategies with 1.04 million shares, Larry Robbins’ Glenview Capital with 787,168 shares, and David Harding’s Winton Capital Management with 621,457 shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!